Metabolite T 2 is necessary for accurate quantification of the absolute concentration of metabolites using long-echo-time (TE) acquisition schemes. However, lengthy data acquisition times pose a major challenge to mapping metabolite T 2 . In this study we used proton echo-planar spectroscopic imaging (PEPSI) at 3T to obtain fast T 2 maps of three major cerebral metabolites: N-acetyl-aspartate (NAA), creatine (Cre), and choline (Cho). We showed that PEPSI spectra matched T 2 values obtained using single-voxel spectroscopy (SVS). Data acquisition for 2D metabolite maps with a voxel volume of 0.95 ml (32 ؋ 32 image matrix) can be completed in 25 min using five TEs and eight averages. A sufficient spectral signal-to-noise ratio (SNR) for T 2 estimation was validated by high Pearson's correlation coefficients between logarithmic MR signals and TEs (R 2 ؍ 0.98, 0.97, and 0.95 for NAA, Cre, and Cho, respectively). In agreement with previous studies, we found that the T 2 values of NAA, but not Cre and Cho, were significantly different between gray matter (GM) and white matter (WM; P < 0.001). The difference between the T 2 estimates of the PEPSI and SVS scans was less than 9%. Consistent spatial distributions of T 2 were found in six healthy subjects, and disagreement among subjects was less than 10%. In summary, the PEPSI technique is a robust method to obtain fast mapping of metabolite Key words: proton echo-planar spectroscopic imaging; singlevoxel spectroscopy; T 2 relaxation time; cerebral metabolites; gray/white matter difference Estimation of the relaxation times of metabolites is necessary for accurate quantification of metabolite concentrations using long-echo-time (TE) acquisition schemes (1-3). Given the T2 relaxation time, metabolite signals acquired at different TEs can be extrapolated to obtain the signal at TE ϭ 0 and thus estimate the concentration of the metabolite (4). Differences in T2 decay are negligible only for short-TE methods (with TE below 10 ms). In several pathological conditions, such as edema and ischemic stroke (5-8), interactions between cerebral metabolites and macromolecules and proteins are known to modify the biochemical environments of the metabolites, which in turn alters the motion-sensitive T2 relaxation time. Accurate estimation of metabolite T2 is therefore especially important in clinical applications of magnetic resonance spectroscopy (MRS) to ascertain whether changes in metabolite MR signals are derived from fluctuations in the metabolite concentration or from changes in the metabolite relaxation time (2,9). In addition to providing information about metabolite concentration, T2 values may give complementary information about metabolite behavior, as has been suggested by studies of brain tumor (9), ischemic stroke (5-7,10), virus infection (11), drug abuse (12), and other neurological disorders (13-15).The T2 relaxation times of metabolites can be measured by collecting multiple spectra over a range of TEs and then fitting the MR signals as a function of TE (1-3,5,10). Se...